Eyal Attar
Overview
Explore the profile of Eyal Attar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narayan R, Blonquist T, Emadi A, Hasserjian R, Burke M, Lescinskas C, et al.
Cancer
. 2019 Dec;
126(6):1264-1273.
PMID: 31860140
Background: Outcomes for patients with relapsed/refractory acute myeloid leukemia (R/R AML) remain poor. Novel therapies specifically targeting AML are of high interest. Brentuximab vedotin (BV) is an antibody-drug conjugate that...
2.
Brunner A, Neuberg D, Wander S, Sadrzadeh H, Ballen K, Amrein P, et al.
Cancer
. 2018 Nov;
125(4):541-549.
PMID: 30422308
Background: Acute myeloid leukemia (AML) cells harboring mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) produce the oncometabolite 2-hydroxyglutarate (2HG). This study prospectively evaluated the 2HG levels,...
3.
Yeh A, Khan M, Harlow J, Biswas A, Akter M, Ferdous J, et al.
J Glob Oncol
. 2018 Sep;
4:1-10.
PMID: 30241180
Purpose: Treatment of malignant and nonmalignant hematologic diseases with hematopoietic stem-cell transplantation (HSCT) was first described almost 60 years ago, and its use has expanded significantly over the last 20...
4.
Cho J, Yusuf R, Kook S, Attar E, Lee D, Park B, et al.
J Clin Invest
. 2014 Jun;
124(7):3159-71.
PMID: 24937426
Purinergic receptors of the P2Y family are G protein-coupled surface receptors that respond to extracellular nucleotides and can mediate responses to local cell damage. P2Y-dependent signaling contributes to thrombotic and/or...
5.
Omer A, Kim H, Yalamarti B, McAfee S, Dey B, Ballen K, et al.
Am J Hematol
. 2014 Mar;
89(7):698-705.
PMID: 24668776
We performed a retrospective study of the engraftment syndrome (ES) as defined by the Spitzer Criteria in adult patients undergoing allogeneic hematopoietic cell transplantation (HCT) for various hematological malignancies at...
6.
Yeh A, Brunner A, Spitzer T, Chen Y, Coughlin E, McAfee S, et al.
Biol Blood Marrow Transplant
. 2014 Feb;
20(5):730-4.
PMID: 24530972
Graft-versus-host disease (GVHD) is a donor T cell driven response against host tissue that can complicate allogeneic hematopoietic stem cell transplantation (HSCT). During acute GVHD, endogenous adjuvants such as uric...
7.
Krause D, Fulzele K, Catic A, Sun C, Dombkowski D, Hurley M, et al.
Nat Med
. 2013 Oct;
19(11):1513-7.
PMID: 24162813
Like their normal hematopoietic stem cell counterparts, leukemia stem cells (LSCs) in chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) are presumed to reside in specific niches in the...
8.
ODonnell M, Tallman M, Abboud C, Altman J, Appelbaum F, Arber D, et al.
J Natl Compr Canc Netw
. 2013 Sep;
11(9):1047-55.
PMID: 24029121
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this...
9.
Greenberg P, Attar E, Bennett J, Bloomfield C, Borate U, de Castro C, et al.
J Natl Compr Canc Netw
. 2013 Jul;
11(7):838-74.
PMID: 23847220
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid...
10.
Omer A, Ziakas P, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee S, et al.
Biol Blood Marrow Transplant
. 2013 Jun;
19(8):1190-6.
PMID: 23747459
Invasive fungal disease (IFD) is a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HCT). We performed a retrospective review of 271 adults with a hematologic malignancy...